Cara L Alfaro - FDA Investigator Report

Designation: CLINICAL ANALYST

Duty Station: Silver Spring MD 20993-0002

Organizations: DHHS FDA CDER OMPT CDER OC OSI DCCE GCPAB

Overview Statistics

4
Total Inspections
0
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 5 days
Shortest Inspection: 4 days
Average Length: 4.8 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Cara L Alfaro's Recent Inspections

DateCompanyCityCountryFEI Number483
2025-03-27Eli Lilly & CompanyIndianapolisUnited States1819470
2019-02-01Nektar TherapeuticsSan FranciscoUnited States3008943810
2017-12-08David Kudrow, M.D.Santa MonicaUnited States3008771907
2016-11-18Julio C. Castro-Gayol, M.D.HialeahUnited States3012801648

Sign Up to get the complete report.

Download 483s and EIRs for Cara L Alfaro

Cara L Alfaro - Co-Inspectors

NameInspectionsLast Inspection
Joanne M Schlossin12025
Dustin R Abaonza12019
Lakecha N Lewis12017
Craig A Garmendia12016

Cara L Alfaro's Active Locations

  • United States

Cara L Alfaro's Year-wise Inspection Count

  • 2016:1 inspections
  • 2017:1 inspections
  • 2019:1 inspections
  • 2025:1 inspections
Last Updated: 2025-05-14 06:11:22